Proteins that interact with Clostridium difficile cytotoxin b

A Clostridium difficile and cytotoxin technology, applied in the field of protein engineering, can solve the problem of unclear host receptor protein

Active Publication Date: 2015-09-16
PEKING UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, little is known about the cellular mechanism of C. difficile infection, especially the mechanism of entry of toxin proteins, and the host receptor proteins used are unknown

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Proteins that interact with Clostridium difficile cytotoxin b
  • Proteins that interact with Clostridium difficile cytotoxin b
  • Proteins that interact with Clostridium difficile cytotoxin b

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Example 1 Whole genome shRNA library screening

[0030] The shRNA library was purchased from Open-biosystem, with a total of 65,000 shRNAs targeting 20,000 human genes. The library was constructed in HeLa cells by lentiviral system. Cultured 2×10 using medium containing 70pg / mL TcdB 6 After 8 hours, the cells infected by TcdB were removed with a pipette and replaced with normal medium for 3 days. After repeating the operation 6 times, HeLa cells resistant to TcdB were collected ( figure 1 ), using primers (5'-ACGTCGAGGTGCCCGAAGGA-3' and 5'-TACATCTGTGGCTTCACTA-3') for PCR amplification, and further confirmed by deep sequencing that the shRNA against CSPG4 can inhibit the toxicity of TcdB ( figure 2 ).

Embodiment 2

[0031] Example 2 CSPG4 gene knockout

[0032] The sequence of TALENs against the CSPG4 gene is as follows: 5'-TCCAGCCCCCGGCCT-3'(TALEN L ), 5'-CTGGCCAACATAGTC-3'(TALENR ). The target sequence used in the CRISPR system for the CSPG4 gene is: 5'-TTGGCCAGACTTGCATCCG-3', and the gRNA sequence is: 5'-GTTTTAGGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTTT-3'.

[0033] After transfecting TALENs or CRISPR system plasmids into cells, single clones were selected, and CSPG4 gene knockout cells were determined by Western Blot. After obtaining the CSPG4 gene knockout cell line, compare wild-type HeLa cells and CSPG4 overexpression HeLa cells, use TcdB to treat, and pass the cell shape ( image 3 ) and cell death ( Figure 4 ) and other phenotypes to evaluate the toxicity of TcdB.

Embodiment 3

[0034] Example 3 The expression level of CSPG4 directly affects the binding of TcdB to the cell surface

[0035] After synchronous culture of the above CSPG4 knockout HeLa cells and CSPG4 overexpression HeLa cells obtained by lentivirus infection, they were cultured at 4°C for one hour with a medium containing 10 μg / mL TcdB. It was further washed 5 times with PBS to wash away TcdB not bound to the cell surface. After the cells were lysed, the relationship between the expression level of CSPG4 and the amount of TcdB bound to the cell surface was determined by Western Blot. At the same time, after culturing at 37°C for half an hour with a medium containing 10 μg / mL TcdB, use FractionPREP TM The Cell Fraction Kit was used to separate the cell membrane structure, and the relationship between the expression level of CSPG4 and the amount of TcdB in the cell membrane was determined by Western Blot ( Figure 5 ).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a protein interacted with clostridium difficile cytotoxin B. The protein is chondroitin sulfate protein polysaccharide CSPG4 or a polypeptide formed by 640 amino acids at the N end of the CSPG4 protein. The invention firstly finds that the CSPG4 has the function of a clostridium difficile cytotoxin B cell receptor, the toxicity of the clostridium difficile cytotoxin B can be obviously reduced by restraining the expression or the function of the CSPG4, and a new thought is provided for treating the clostridium difficile infection.

Description

technical field [0001] The invention relates to the field of protein engineering, in particular to a protein interacting with Clostridium difficile cytotoxin B. Background technique [0002] Clostridium difficile (Clostridium difficile) is an anaerobic Gram-positive bacterium, which was first discovered in 1935. clindamycin, etc.) caused by pseudomembranous colitis, which gradually received attention. At present, the scientific community has recognized that Clostridium difficile infection is the main cause of clinical antibiotic-associated diarrhea (antibiotic-associated diarrhea, AAD) and pseudomembranous colitis (pseudomenbranous colitis, PMC). According to a document released by the US Centers for Disease Control and Prevention in 2013 (ANTIBIOTIC RESISTANCE THREATS in the United States, 2013), in the United States alone, more than 250,000 people are infected with Clostridium difficile each year, and 14,000 of them die as a result. C. difficile infection costs more than...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/47C12N15/85C12N5/071A61K38/17A61P31/04G01N33/68
CPCA61K38/00C07K14/4725G01N33/56911G01N2333/4722
Inventor 魏文胜袁鹏飞
Owner PEKING UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products